These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 22532567)

  • 1. Androgen receptor splice variants activate androgen receptor target genes and support aberrant prostate cancer cell growth independent of canonical androgen receptor nuclear localization signal.
    Chan SC; Li Y; Dehm SM
    J Biol Chem; 2012 Jun; 287(23):19736-49. PubMed ID: 22532567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of nuclear import of the domain-specific androgen receptor in association with the importin alpha/beta and Ran-guanosine 5'-triphosphate systems.
    Kaku N; Matsuda K; Tsujimura A; Kawata M
    Endocrinology; 2008 Aug; 149(8):3960-9. PubMed ID: 18420738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The N-terminal domain of the androgen receptor drives its nuclear localization in castration-resistant prostate cancer cells.
    Dar JA; Masoodi KZ; Eisermann K; Isharwal S; Ai J; Pascal LE; Nelson JB; Wang Z
    J Steroid Biochem Mol Biol; 2014 Sep; 143():473-80. PubMed ID: 24662325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen induces a switch from cytoplasmic retention to nuclear import of the androgen receptor.
    Ni L; Llewellyn R; Kesler CT; Kelley JB; Spencer A; Snow CJ; Shank L; Paschal BM
    Mol Cell Biol; 2013 Dec; 33(24):4766-78. PubMed ID: 24100013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Hsp90 inhibitor, 17-AAG, prevents the ligand-independent nuclear localization of androgen receptor in refractory prostate cancer cells.
    Saporita AJ; Ai J; Wang Z
    Prostate; 2007 Apr; 67(5):509-20. PubMed ID: 17221841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis for the nuclear import of the human androgen receptor.
    Cutress ML; Whitaker HC; Mills IG; Stewart M; Neal DE
    J Cell Sci; 2008 Apr; 121(Pt 7):957-68. PubMed ID: 18319300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased PrLZ-mediated androgen receptor transactivation promotes prostate cancer growth at castration-resistant stage.
    Li L; Xie H; Liang L; Gao Y; Zhang D; Fang L; Lee SO; Luo J; Chen X; Wang X; Chang LS; Yeh S; Wang Y; He D; Chang C
    Carcinogenesis; 2013 Feb; 34(2):257-67. PubMed ID: 23104178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation and targeting of androgen receptor nuclear localization in castration-resistant prostate cancer.
    Lv S; Song Q; Chen G; Cheng E; Chen W; Cole R; Wu Z; Pascal LE; Wang K; Wipf P; Nelson JB; Wei Q; Huang W; Wang Z
    J Clin Invest; 2021 Feb; 131(4):. PubMed ID: 33332287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel membrane-associated androgen receptor splice variant potentiates proliferative and survival responses in prostate cancer cells.
    Yang X; Guo Z; Sun F; Li W; Alfano A; Shimelis H; Chen M; Brodie AMH; Chen H; Xiao Z; Veenstra TD; Qiu Y
    J Biol Chem; 2011 Oct; 286(41):36152-36160. PubMed ID: 21878636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melanoma antigen-A11 (MAGE-A11) enhances transcriptional activity by linking androgen receptor dimers.
    Minges JT; Su S; Grossman G; Blackwelder AJ; Pop EA; Mohler JL; Wilson EM
    J Biol Chem; 2013 Jan; 288(3):1939-52. PubMed ID: 23172223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen receptor splice variants are resistant to inhibitors of Hsp90 and FKBP52, which alter androgen receptor activity and expression.
    Shafi AA; Cox MB; Weigel NL
    Steroids; 2013 Jun; 78(6):548-54. PubMed ID: 23380368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel androgen receptor splice variant is up-regulated during prostate cancer progression and promotes androgen depletion-resistant growth.
    Guo Z; Yang X; Sun F; Jiang R; Linn DE; Chen H; Chen H; Kong X; Melamed J; Tepper CG; Kung HJ; Brodie AM; Edwards J; Qiu Y
    Cancer Res; 2009 Mar; 69(6):2305-13. PubMed ID: 19244107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interplay between Cytoplasmic and Nuclear Androgen Receptor Splice Variants Mediates Castration Resistance.
    Zhan Y; Zhang G; Wang X; Qi Y; Bai S; Li D; Ma T; Sartor O; Flemington EK; Zhang H; Lee P; Dong Y
    Mol Cancer Res; 2017 Jan; 15(1):59-68. PubMed ID: 27671337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FOXO1 binds to the TAU5 motif and inhibits constitutively active androgen receptor splice variants.
    Bohrer LR; Liu P; Zhong J; Pan Y; Angstman J; Brand LJ; Dehm SM; Huang H
    Prostate; 2013 Jul; 73(10):1017-27. PubMed ID: 23389878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism underlying the retarded nuclear translocation of androgen receptor splice variants.
    Liu Y; Wang Y; Wang F; Pan J; Xu J; Li J; Zhou C; Ding G; Wu Y; Liu X; Sheng J; Huang H
    Sci China Life Sci; 2019 Feb; 62(2):257-267. PubMed ID: 30267260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen receptor variants occur frequently in castration resistant prostate cancer metastases.
    Zhang X; Morrissey C; Sun S; Ketchandji M; Nelson PS; True LD; Vakar-Lopez F; Vessella RL; Plymate SR
    PLoS One; 2011; 6(11):e27970. PubMed ID: 22114732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor.
    Watson PA; Chen YF; Balbas MD; Wongvipat J; Socci ND; Viale A; Kim K; Sawyers CL
    Proc Natl Acad Sci U S A; 2010 Sep; 107(39):16759-65. PubMed ID: 20823238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of the transcriptional coactivator FHL2 licenses activation of the androgen receptor in castrate-resistant prostate cancer.
    McGrath MJ; Binge LC; Sriratana A; Wang H; Robinson PA; Pook D; Fedele CG; Brown S; Dyson JM; Cottle DL; Cowling BS; Niranjan B; Risbridger GP; Mitchell CA
    Cancer Res; 2013 Aug; 73(16):5066-79. PubMed ID: 23801747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the HSP90-associated cochaperone p23 in enhancing activity of the androgen receptor and significance for prostate cancer.
    Reebye V; Querol Cano L; Lavery DN; Brooke GN; Powell SM; Chotai D; Walker MM; Whitaker HC; Wait R; Hurst HC; Bevan CL
    Mol Endocrinol; 2012 Oct; 26(10):1694-706. PubMed ID: 22899854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AR intragenic deletions linked to androgen receptor splice variant expression and activity in models of prostate cancer progression.
    Li Y; Hwang TH; Oseth LA; Hauge A; Vessella RL; Schmechel SC; Hirsch B; Beckman KB; Silverstein KA; Dehm SM
    Oncogene; 2012 Nov; 31(45):4759-67. PubMed ID: 22266865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.